2)Results for the first quarter of 2007 include pre-tax charges of
$10.7 million associated with workforce reductions in response to
reduced volume levels. Of these costs, $3.9 million and $6.8 million,
respectively, were included in cost of services and selling, general and
administrative expenses.
3)Other operating expense, net represents miscellaneous income and expense
items related to operating activities including gains and losses
associated with the disposal of operating assets and provisions for
restructurings and other special charges. For the three months ended
March 31, 2007, other operating expense, net includes a $4.0 million
charge related to in-process research and development expense associated
with HemoCue, which the Company acquired on January 31, 2007.
4)The following table summarizes the approximate impact of various items
on year-over-year comparisons for certain revenue metrics reported for
the quarter ended March 31, 2008, and is included for informational
purposes only:
Continuing Operations
Three Months Ended
March 31, 2008
Consolidated Volume Revenue
Revenue Growth Growth per Requisition
Growth
Reported: 16.9% 5.6% 10.8%
Impact on comparisons to
prior year of:
Impact of contract change (0.8)% (1.6)% 0.4%
Acquisitions:
AmeriPath 13.0% 5.8% 7.8%
Other 0.5%
'/>"/>
| SOURCE Quest Diagnostics Incorporated Copyright©2008 PR Newswire. All rights reserved |